SANTOS DA SILVA JORGE (Chief Executive Officer) sold 4.0% of their position (123.61K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $6.80M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/29/2024ACC: 0001213900-24-018675
DirectorOfficer· Chief Executive Officer
Since Apr 2022
-123.61K
Net shares
Net seller
$6.80M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
123.61K disposed
Non-Derivative Transactions3
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−62.81K
Price / share
$55.00
Trade value
$3.45M
% of position
2.0%
2/27/2024
3.11M→3.04M
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−56.06K
Price / share
$55.00
Trade value
$3.08M
% of position
1.8%
2/28/2024
3.04M→2.99M
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−4.74K
Price / share
$55.89
Trade value
$264.92K
% of position
0.2%
2/29/2024
2.99M→2.98M
Total
Net shares
−123.61K
Net value
-$6.80M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 2/27/2024 | S · Sale | −62.81K | $55.00 | $3.45M | 2.0% | 3.11M | 3.04M |
| Class A ordinary shares, par value $0.0001 per share Direct | 2/28/2024 | S · Sale | −56.06K | $55.00 | $3.08M | 1.8% | 3.04M | 2.99M |
| Class A ordinary shares, par value $0.0001 per share Direct | 2/29/2024 | S · Sale | −4.74K | $55.89 | $264.92K | 0.2% | 2.99M | 2.98M |
| Total | −123.61K | -$6.80M | ||||||
Derivative Transactions0
No derivative transactions reported